[Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung]. 1986

H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki

Twenty-three patients with inoperable non-small cell lung cancer were treated with a combination chemotherapy of CDDP 100 mg/m2, ADM 30 mg/m2 and MMC 8 mg/m2 (PAM). Ten cases were adenocarcinoma, 9 cases were squamous cell carcinoma and 4 cases were large cell carcinoma. In 21 evaluable cases, partial response was obtained in 47.6%. (The response rates were 40.0% in patients with adenocarcinoma, 50.0% in those with squamous cell carcinoma and 66.7% in those with large cell carcinoma.) Leukocytopenia of less than 4,000/mm3 occurred in 100% of cases, thrombocytopenia of less than 100,000/mm3 occurred in 81.0%, and anemia(fall in hemoglobin over 2.0 g/dl) occurred in 66.7%. A transient elevation of Cr (over 1.5 mg/dl) and/or BUN (over 30 mg/dl) was observed in 23.8%. Nausea and vomiting occurred in almost all patients. No death occurred due to toxicity of PAM. These results demonstrate that PAM is an effective combination chemotherapy in patients with non-small cell carcinoma of the lung.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
December 1990, Journal of chemotherapy (Florence, Italy),
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
February 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
December 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
February 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
October 1981, Cancer,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
January 1985, Medical and pediatric oncology,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
September 1985, Gan no rinsho. Japan journal of cancer clinics,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
January 1991, Cancer chemotherapy and pharmacology,
H Nakano, and M Kurihara, and R Saito, and A Takise, and S Tsuchiya, and K Minato, and K Takehara, and T Saruya, and H Kuwabara, and R Fueki
January 1979, Cancer treatment reports,
Copied contents to your clipboard!